News

Opinion
Zacks Investment Research on MSN13hOpinion
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...
The crown jewel of Alphabet's business right now is Google Cloud. Growing revenue at 28% year over year, the division is ...
You might spot vehicles that have clearly traveled some distance, dust from rural roads still clinging to their wheel wells, drivers who’ve made the trek specifically for this shopping experience. The ...
The Dollar Tree at 1960 Cliff Lake Road isn’t just another discount store – it’s a financial oasis where Minnesotans transform their hard-earned dollars into carts overflowing with treasures. You ...
Fewer people crossed the threshold of having $1 million or more in their retirement accounts in the first quarter of 2025 as ...
Average 401(k) retirement balances fell 3% from late last year through the first three months this year, according to ...
The 2025 NHL Scouting Combine presented by Fanatics took place last week at KeyBank Center and LECOM HarborCenter in Buffalo.
Lopez-Lira has been experimenting with ChatGPT, DeepSeek and Grok to see if AI can be used to pick stocks. So far, he’s ...
Eli Lilly & Co. increased sales of weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second full ...
Booking Holdings is building one-stop travel platform, leveraging network effects and multiple verticals to outpace ...
Amarin faces revenue declines due to generic competition, with losses outpacing revenue. Explore challenges, risks, and M&A ...
In this podcast, Motley Fool contributors Anand Chokkavelu, Jason Hall, and Matt Frankel discuss: Jason's and Matt's picks for the stock of the summer. "News or noise" with Dollar General, Disney, and ...